未登录 分享 收藏
Real-World Outcomes of Nivolumab Plus Ipilimumab Versus Pembrolizumab Plus Axitinib for First-Line Treatment of Advanced Renal Cell Carcinoma 纳武利尤单抗联合伊匹木单抗与帕博利珠单抗联合阿昔替尼用于晚期肾细胞癌一线治疗的真实世界结局比较 Geynisman, Daniel M.; John, William S.; Miller, Taavy A.; Asgarisabet, Parisa; Falkenstein, Angelica; Savill, Kristin M. Zimmerman; Yin, Xin; del Tejo, Viviana; Guttenplan, Sarah B.; Rosenblatt, Lisa 分享 收藏
Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Nivolumab Plus Ipilimumab in the United States (vol 8,e2400132,2024) Doshi, Gurjyot K.; Osterland, Andrew J.; Shi, Ping; Yim, Annette; Del Tejo, Viviana; Guttenplan, Sarah B.; Eiffert, Samantha; Yin, Xin; Rosenblatt, Lisa; Conkling, Paul R. 分享 收藏
Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Nivolumab Plus Ipilimumab in the United States Doshi, Gurjyot K.; Osterland, Andrew J.; Shi, Ping; Yim, Annette; Del Tejo, Viviana; Guttenplan, Sarah B.; Eiffert, Samantha; Yin, Xin; Rosenblatt, Lisa; Conkling, Paul R. 分享 收藏
分享 收藏
Real-world (RW) characteristics and outcomes in patients (pts) with muscle-invasive urothelial carcinoma (MIUC) treated with adjuvant nivolumab (NIVO) with or without neoadjuvant chemotherapy (NAC) 真实世界（RW）中接受辅助纳武利尤单抗（NIVO）治疗，联合或不联合新辅助化疗（NAC）的肌肉浸润性尿路上皮癌（MIUC）患者的特征与结局 Ebrahimi, H.; Barragan-Carrillo, R.; John, W. S.; Lucht, S.; Miller, T.; Pathak, P.; Bland, E.; Gordon, S.; Laney, J.; Klink, A. J.; Feinberg, B. A.; Singh, N.; Alonso, C.; Patel, M.; Rosenblatt, L. C.; Yin, X.; Chehrazi-Raffle, A. 分享 收藏
Long-Term Temporal Trends of Real-World Healthcare Costs Associated with Nivolumab Plus Ipilimumab and Pembrolizumab Plus Axitinib as First-Line Treatment for Advanced or Metastatic Renal Cell Carcinoma Du, Ella Xiaoyan; Betts, Keith A.; Wang, Travis; Kitchen, Sophie A.; He, Xuanhao; Yin, Xin; Guttenplan, Sarah B.; Beauchamp, Karen; Delgado, Andrew; Rosenblatt, Lisa 分享 收藏
Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214 Mantia, Charlene M.; Jegede, Opeyemi A.; Plimack, Elizabeth R.; Powles, Thomas; Motzer, Robert J.; Tannir, Nizar M.; Lee, Chung-Han; Tomita, Yoshihiko; Voss, Martin H.; Choueiri, Toni K.; Rini, Brian, I; Hammers, Hans J.; Escudier, Bernard; Albiges, Laurence; Rosenblatt, Lisa; Atkins, Michael B.; Regan, Meredith M.; McDermott, David F. 分享 收藏
Racial differences in characteristics and outcomes of adjuvant nivolumab for muscle-invasive urothelial carcinoma (MIUC) in the real-world setting Barragan-Carrillo, Regina; Chehrazi-Raffle, Alexander; Feinberg, Bruce; John, William S.; Miller, Taavy A.; Lucht, Sarah; Pathak, Prathamesh; Bland, Emily; Gordon, Sarah; Laney, JaLyna; Klink, Andrew J.; Ebrahimi, Hedyeh; Singh, Nisha; Alonso, Carmelo; Patel, Miraj; Rosenblatt, Lisa; Yin, Xin 分享 收藏
Characteristics of patients with advanced renal cell carcinoma (aRCC) who received first-line (1L) nivolumab plus cabozantinib (NIVO plus CABO), pembrolizumab plus lenvatinib (PEM plus LEN), or nivolumab (NIVO) monotherapy in the real-world (RW) setting Zarrabi, Kevin K.; Miron, Benjamin; Yin, Xin; Rosenblatt, Lisa; Guttenplan, Sarah B.; John, William; Miller, Taavy A.; Asgarisabet, Parisa; Pathak, Prathamesh; Ahlquist, Monica; Gash, Yul Brian; Geynisman, Daniel M. 分享 收藏
分享 收藏
Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences Cohen, Alexander T.; Sah, Janvi; Dhamane, Amol D.; Hines, Dionne M.; Lee, Theodore; Rosenblatt, Lisa; Emir, Birol; Keshishian, Allison; Yuce, Huseyin; Luo, Xuemei 分享 收藏
分享 收藏
Real-world management of immune-related adverse events in the community setting Johnson, D. B.; Bruno, D.; Rioth, M.; Zhang, C.; Palaia, J.; Pisupati, R.; Bond, C.; Rosenblatt, L. C.; Broome, R. G.; Teka, M.; Kluger, H. 分享 收藏
Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants Lip, Gregory Y. H.; Murphy, Richard R.; Sahiar, Farhad; Ingall, Timothy J.; Dhamane, Amol D.; Ferri, Mauricio; Hlavacek, Patrick; Preib, Madison T.; Keshishian, Allison; Russ, Cristina; Rosenblatt, Lisa; Yuce, Huseyin; Deitelzweig, Steven 分享 收藏
Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease Cohen, Alexander T.; Sah, Janvi; Dhamane, Amol D.; Lee, Theodore; Rosenblatt, Lisa; Hlavacek, Patrick; Emir, Birol; Delinger, Rachel; Yuce, Huseyin; Luo, Xuemei 分享 收藏
Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic Status Cohen, Alexander T.; Sah, Janvi; Dhamane, Amol D.; Lee, Theodore; Rosenblatt, Lisa; Hlavacek, Patrick; Emir, Birol; Keshishian, Allison; Yuce, Huseyin; Luo, Xuemei 分享 收藏
Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity Deitelzweig, Steven; Keshishian, Allison; Kang, Amiee; Dhamane, Amol D.; Luo, Xuemei; Klem, Christian; Rosenblatt, Lisa; Mardekian, Jack; Jiang, Jenny; Yuce, Huseyin; Lip, Gregory Y. H. 分享 收藏
Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients Deitelzweig, Steven; Keshishian, Allison; Kang, Amiee; Dhamane, Amol D.; Luo, Xuemei; Balachander, Neeraja; Rosenblatt, Lisa; Mardekian, Jack; Jiang, Jenny; Yuce, Huseyin; Lip, Gregory Y. H. 分享 收藏
Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population Guo, Jennifer D.; Hlavacek, Patrick; Rosenblatt, Lisa; Keshishian, Allison; Russ, Cristina; Mardekian, Jack; Ferri, Mauricio; Poretta, Tayla; Yuce, Huseyin; McBane, Robert 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
